Rohan Garje, MD
@rohangarjemd
Associate Professor, Chief of Genitourinary Medical Oncology, Miami Cancer Institute, Baptist Health
ID: 1325455522384982017
08-11-2020 15:10:09
432 Tweet
603 Followers
400 Following
Petros Grivas Manmeet Ahluwalia, MD, MBA, FASCO Vivek Subbiah, MD Ishwaria Subbiah, MD MS FASCO Julie Gralow Neeta Somaiah, MD Vamsi Velcheti, MD MBA FASCO Rohan Garje, MD Great job Petros Grivas on such an amazing overview of the revolution in metastatic urothelial ca. what a year 2024 was with new game changer approval of EV-pembro, tumor agnostic approval of T-dxD (Her2+), approval of Gem-Cis Nivo . Congrats on your leadership of Trophy trial
and the other 1 Cancer Treat Res Commun doi: 10.1016/j.ctarc.2025.100864. Many yrs of work, many collaborators Ryan Reis Matthew Robert Kroll Aliasger Salem Rohan Garje, MD Bilal G Rahim Umang Swami University of Iowa Health Care Mayo Clinic Comprehensive Cancer Center ππ‘ππ§ππ₯ππ« πππ«π€ ππ π πππ OncLive.com OncoDaily Katie Coleman OncoAlert
Experts Break Down Practice-Informing Presentations From the 2025 Genitourinary Cancers Symposium Rohan Garje, MD Tanya Dorff Guru P. Sonpavde, MD Bradley McGregor MD Anderson Cancer Center Miami Cancer Institute Research University of Glasgow City of Hope Dana-Farber ASCO #GU25 #pcsm #blcsm #kcsm onclive.com/view/experts-bβ¦
Excited to co-chair this first GU summit with Mehmet Asim Bilen,MD in Atlanta with great lineup of speakers Pedro C Barata, MD MSc FACP ππ‘ππ§ππ₯ππ« πππ«π€ ππ π πππ Rohan Garje, MD Benjamin L Maughan Binay Shah, MD, MHA Arnab Basu Viraj Master Matt Campbell MD, MS Bassel Nazha, MD, MPH and many more canβt find on X, 15 travel grants offered to trainees.
π We kick off #AtlantaGU25 with ππ‘ππ§ππ₯ππ« πππ«π€ ππ π πππ from Norton Healthcare, Rohan Garje, MD from Baptist Health and Dr. Louis Crain Garrot from Georgia Cancer Specialists discussing #prostatecancer π¬. Session Chair: Dr. Bradley Carthon from Winship Cancer Institute of Emory University. π Visit education.binayfoundation.org
#AtlantaGU25 starting with prostate cancer. Chaired by Winship Cancer Institute of Emory University Dr Brad Carthon. Lots of updates in both the metastatic hormonal sensitive and castrate resistant spaces with ππ‘ππ§ππ₯ππ« πππ«π€ ππ π πππ and Rohan Garje, MD. Binaytara
βοΈDr. Pedro Barata gives a very thoughtful discussion of how to navigate 1st line RCC data in 2025 to provide best care for our patients. LOVE the updated table below. #AtlantaGU25 Binaytara Yousef Zakharia Mehmet Asim Bilen,MD Rohan Garje, MD Baptist Health Winship Cancer Institute of Emory University Binaytara
Binaytara University Hospitals Benjamin L Maughan Huntsman Cancer Institute Winship Cancer Institute of Emory University Mehmet Asim Bilen,MD Yousef Zakharia Arnab Basu Rohit Kansal Rohan Garje, MD ππ‘ππ§ππ₯ππ« πππ«π€ ππ π πππ in the room already thinking of the next trial in GU tumors
If you can get it (especially in πΊπΈ), can't argue with the cost of BCG: 1 yr, $1800 π #EAU25 debate -- Gianluca Giannarini making the point that BCG is still the best option for HR NMIBC UroToday.com Discussing European Urology paper from Scilipoti, Marco Moschini Roger Li Sarah P. Psutka MD MS
ASCO 2024 mCRPC Update: π Put patients first: tailor to comorbidities, life expectancy & access 𧬠Genomic testing (BRCA1/2, HRR, MSI, TMB) = must 𧬠PARP inhibitors: for BRCA1/2, maybe others β’οΈ Lu-PSMA: for PSMA+ after ARPI & chemo β No ARPI after ARPIβunless no options
π¨ New ASCO Guideline on #mCRPC just published! Glad to co-author recs on sequencing, #PARP inhibitors, #genomics, chemo & radiopharmaceuticals Grateful to expert panel R. Bryan Rumble Irbaz Riaz MD,MS,MBI,PhD #RahulParikh Alan H Bryce Journal of Clinical Oncology OncoAlert OncLive.com πascopubs.org/doi/10.1200/JCβ¦
The Updated ASCO Guidelines on Metastatic Castration-Resistant Prostate Cancer - Rohan Garje, MD R. Bryan Rumble ASCO oncodaily.com/url/289209 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld #ASCO #mCRPC
